Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vistagen Therapeutics (VTGN) Debt to Equity (2020)

Historic Debt to Equity for Vistagen Therapeutics (VTGN) over the last 4 years, with Q3 2020 value amounting to $0.02.

  • Vistagen Therapeutics' Debt to Equity changed N/A to $0.02 in Q3 2020 from the same period last year, while for Sep 2020 it was $0.02, marking a year-over-year change of. This contributed to the annual value of -$0.0 for FY2013, which is N/A changed from last year.
  • As of Q3 2020, Vistagen Therapeutics' Debt to Equity stood at $0.02.
  • In the past 5 years, Vistagen Therapeutics' Debt to Equity ranged from a high of $0.02 in Q3 2020 and a low of -$0.02 during Q2 2020